Loading...
Cemiplimab
Pida mas información
935106861
info@markelab.com
Precio
412.5€ (100 µg)
proveedor
Abbexareference
abx831484Tested Applications
ELISA, WBreactivity
Humanstatus
This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications (RUOclonality
MonoclonalDescripción
Cemiplimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, Cemiplimab is a fully human PD-1 antibody. The first indication for the marketing application is metastatic/locally advanced cutaneous squamous cell carcinoma (Cutaneous Squamous Cell Carcinoma, CSCC). It is an intravenous immunotherapy targeting the PD-1 pathway, which can help the immune system fight cancer cells.
Características del producto
category
Biosimilars
host
Human
clonality
Monoclonal
reactivity
Human
immunogen target
PDCD1/PD1/CD279
host
Human
isotype
IgG4 Kappa
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB
size 1
100 µg
size 2
1 mg
expression
Recombinant
purity
> 95%
purification
Purified from cell culture supernatants by Protein A/G chromatography.
buffer
0.01 M PBS. pH 7.4.
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
dry ice
No
availability
Shipped within 7-12 working days.
alias
Biosimilars
note
CAS Number 1801342-60-8
Quizá le pueda interesar
Goat MAP28 ELISA Kit
proveedor
FineTestreference
EG0012reactivity
goatstatus
RUOPrecio a consultar
Ver másHRP conjugated Streptavidin
proveedor
FineTestreference
FNSA-0001Tested Applications
ELISA, WBstatus
RUOPrecio a consultar
Ver másHRP conjugated Goat Anti-Mouse FC
proveedor
FineTestreference
FNSA-0002Tested Applications
ELISA, WBreactivity
mousestatus
RUOPrecio a consultar
Ver más